Tanmoy Bera | Medicinal Plants | Best Researcher Award

Prof. Tanmoy Bera | Medicinal Plants | Best Researcher Award

Jadavpur University | India

Author Profile

Scopus

Orcid ID

Google Scholar

DR. TANMOY BERA: A BIOGRAPHY OF A PIONEER IN NANOMEDICINE AND BIOTECHNOLOGY ✨

📚 EARLY ACADEMIC PURSUITS

Dr. Tanmoy Bera’s academic journey began with a deep commitment to the pharmaceutical sciences. After completing his M.Pharm and PhD at Jadavpur University, India, he embarked on a career that would span decades. He began his teaching career as a senior lecturer at Pune University (1986-1992) before returning to his alma mater, Jadavpur University, in 1992 as a Reader. His work quickly gained recognition, and by 2005, he was appointed a visiting professor at the University of Dublin, Ireland. In 2006, he became a Professor at Jadavpur University, where he has continued his impactful career.

🧪 PROFESSIONAL ENDEAVORS

Throughout his career, Dr. Bera has demonstrated an unyielding focus on advancing nanomedicine, bioenergetics, and plant biotechnology. His research has led to the development of innovative drug delivery systems and therapies, particularly for treating asthma, diabetes, and infectious diseases. His work in developing novel antileishmanial agents and combined drug nanoformulations has significantly advanced the field. His efforts are aimed at improving the therapeutic efficacy of treatments, especially in the areas of metabolic and infectious diseases.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINAL PLANTS

Dr. Bera’s contributions have extended beyond the development of new drugs. His innovative nanoformulations, such as those combining curcumin with andrographolide, curcumin with epigallocatechin gallate, and plant extracts from Pueraria tuberosa and Pterocarpus santalinus, have made a lasting impact on the treatment of diabetes and diabetic nephropathy. These advances in nanomedicine are notable for significantly improving solubility and bioavailability, enhancing therapeutic efficacy compared to free drugs.

🌍 IMPACT AND INFLUENCE

Dr. Bera’s work has influenced both academia and industry. He has collaborated with organizations like Organon India and contributed to 91 published journal articles, many of which are indexed in high-impact databases like SCI and Scopus. His research has improved treatments for conditions like asthma, diabetes, and infections, making a tangible difference in the lives of patients.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Bera’s research has been widely cited, with a citation index of 2426. He has contributed significantly to the scientific community, with 91 journal publications in prestigious SCI and Scopus-indexed journals. His academic presence is also reflected in his editorial roles, having served on the editorial boards of Frontiers in Pharmaceutical Sciences and Biomedicine and as a guest editor for Elsevier’s nanomedicine journal.

🏅 HONORS & AWARDS

  • Lifetime Achievement Award in Nanomedicine (Venus International Foundation, 2016)
  • Invited Guest Editor for Nanomedicine (Elsevier, 2017)
  • Editorial Board Member for Frontiers in Pharmaceutical Sciences and Biomedicine (2017)
  • Multiple industry collaborations, including with Organon India for two years.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Bera’s research legacy is built on advancing the understanding and treatment of metabolic diseases, infectious diseases, and drug resistance. His ongoing work promises to further revolutionize nanomedicine and plant biotechnology. As he continues to mentor future generations of scientists, his influence in both academic research and real-world applications remains immense.

🌠 FINAL NOTE

Dr. Tanmoy Bera’s career is a testament to the power of scientific innovation and dedication. His work has brought new treatments to the forefront of modern medicine and has paved the way for further research into nanomedicine and bioenergetics. He continues to shape the future of pharmaceutical sciences, ensuring his legacy endures in both the academic and medical communities.

📑 NOTABLE PUBLICATIONS 

Shellac and locust bean gum coacervated curcumin, epigallocatechin gallate nanoparticle ameliorates diabetic nephropathy in a streptozotocin-induced mouse model
  • Authors: Bhutia, G.T., De, A.K., Bhowmik, M., Bera, T.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024
VALIDATION, STABILITY STUDIES, AND SIMULTANEOUS ESTIMATION OF CO-ENCAPSULATED CURCUMIN, EPIGALLOCATECHIN GALLATE NANOFORMULATION BY RP-HPLC METHOD
  • Authors: Bhutia, G.T., De, A.K., Bera, T.
  • Journal: International Journal of Applied Pharmaceutics
  • Year: 2022
Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India
  • Authors: Sarkar, S., Sahoo, P.K., Pal, R., Bera, T., Nasare, V.D.
  • Journal: Supportive Care in Cancer
  • Year: 2022
Analytical method development, validation and stability studies by RP-HPLC method for simultaneous estimation of andrographolide and curcumin in co-encapsulated nanostructured lipid carrier drug delivery system
  • Authors: De, A.K., Bera, T.
  • Journal: International Journal of Applied Pharmaceutics
  • Year: 2021
Therapeutic potential of andrographolide-loaded nanoparticles on a murine asthma model
  • Authors: Chakraborty, S., Ehsan, I., Mukherjee, B., Debnath, M.C., Bera, T.
  • Journal: Nanomedicine: Nanotechnology, Biology, and Medicine
  • Year: 2019

 

Arthur M. Feldman | Medicinal Plants | Best Researcher Award

Dr. Arthur M. Feldman | Medicinal Plants | Best Researcher Award

Lewis Katz School of Medicine at Temple University | United States

Author Profile

🌟Arthur M. Feldman, MD, PhD: A Legacy of Excellence in Cardiology

📚 EARLY ACADEMIC PURSUITS

Arthur M. Feldman, MD, PhD, embarked on his illustrious academic journey with a foundation in biology at Gettysburg College, where he earned a Bachelor of Arts in 1970. His pursuit of scientific excellence continued with a Master’s degree in Zoology (1973) and a Ph.D. in Physiology (1974) from the University of Maryland, College Park. Driven by a passion for understanding human physiology, he later achieved his MD from LSU School of Medicine in Shreveport in 1981, setting the stage for his impactful career in medicine.

🧪 PROFESSIONAL ENDEAVORS

Dr. Feldman’s career spans decades of distinguished service in academia, research, and clinical practice. Beginning as a Graduate Teaching Assistant at the University of Maryland, he rose through the ranks, holding prestigious positions such as Director of Heart Failure Research at Johns Hopkins and Chief of the Division of Cardiology at the University of Pittsburgh. His leadership extended to serving as Executive Dean at Temple University’s School of Medicine and as the Laura H. Carnell Professor of Medicine. He also demonstrated entrepreneurial acumen by founding companies like Cardiokine, Inc., and Renovacor, Inc., contributing to advancements in cardiac care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINAL PLANTS

Dr. Feldman’s research has profoundly shaped the understanding of heart failure, particularly in receptor-G protein signaling and matrix metalloproteinases. His innovative studies on G protein function in heart failure illuminated pathways for therapeutic interventions, while his work on metalloproteinases offered groundbreaking insights into cardiac remodeling. With over 400 manuscripts, 50 textbook chapters, and four books to his name, his scholarly contributions have earned him an H-index of 93 and more than 86,000 citations.

🌍 IMPACT AND INFLUENCE

As a pioneer in cardiology, Dr. Feldman’s influence extends beyond research. He has trained countless professionals, contributed to seminal guidelines on heart failure management, and played leadership roles in organizations like the Heart Failure Society of America and the American Heart Association. His editorial work for journals like Clinical and Translational Science has further solidified his standing as a thought leader.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Feldman’s academic output is monumental, with key publications that have advanced the fields of heart failure and cardiac physiology. Notable works include studies on adrenergic signaling in failing hearts and the role of metalloproteinases in cardiac remodeling. These publications have shaped clinical practices and fostered new research directions.

🏅 HONORS & AWARDS

Dr. Feldman’s contributions have been recognized with numerous accolades:

  • Lewis Gottlieb Scholar Award (1981)
  • Distinguished Alumnus Award, Gettysburg College (1995)
  • Lifetime Achievement Award, Heart Failure Society of America (2013)
  • Distinguished Scientist Award, American College of Cardiology (2019)
  • Senior Member, National Academy of Inventors (2023)

His consistent inclusion in “Best Doctors in America” reflects his enduring impact on the field.

🌐 LEGACY AND FUTURE CONTRIBUTIONS

As Dr. Feldman continues to contribute to the field through mentorship, research, and innovation, his legacy serves as an inspiration to future generations. His pioneering efforts in cardiology ensure a lasting impact on medical science and patient care.

🌠 FINAL NOTE

Dr. Feldman’s career exemplifies the fusion of academic rigor, clinical expertise, and innovative thinking. His work has not only advanced medical knowledge but also improved the lives of countless patients.

📑 NOTABLE PUBLICATIONS 

The Role of BAG3 Protein Interactions in Cardiomyopathies
  • Authors: Qu, H.-Q., Wang, J.-F., Rosa-Campos, A., Hakonarson, H., Feldman, A.M.
  • Journal: International Journal of Molecular Sciences
  • Year: 2024
Rare variants in cardiomyopathy genes predispose to cardiac injury in severe COVID-19 patients of African or Hispanic ancestry
  • Authors: Qu, H.-Q., Delfiner, M.S., Gangireddy, C., Hakonarson, H., Feldman, A.M.
  • Journal: Journal of Molecular Medicine
  • Year: 2024
Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S BAG3 Variants
  • Authors: Martin, T.G., Pak, H., Gerhard, G.S., Feldman, A.M., Kirk, J.A.
  • Journal: Journal of the American Heart Association
  • Year: 2023
Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart
  • Authors: Wang, J., Tomar, D., Martin, T.G., Kirk, J.A., Feldman, A.M.
  • Journal: JACC: Basic to Translational Science
  • Year: 2023
Precision Medicine: Solving the Mystery of Myocarditis in the Aftermath of SARS-CoV-2
  • Authors: Feldman, A.M., Kasper, E.K., Qu, H.-Q.
  • Journal: JACC: Heart Failure
  • Year: 2023